These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15557207)

  • 1. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
    Endres CJ; Unadkat JD
    Mol Pharmacol; 2005 Mar; 67(3):837-44. PubMed ID: 15557207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
    Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
    Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
    Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.
    SenGupta DJ; Lum PY; Lai Y; Shubochkina E; Bakken AH; Schneider G; Unadkat JD
    Biochemistry; 2002 Feb; 41(5):1512-9. PubMed ID: 11814344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters.
    Hammond JR; Archer RG
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1083-93. PubMed ID: 14634039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
    Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
    J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium.
    Casanello P; Torres A; Sanhueza F; González M; Farías M; Gallardo V; Pastor-Anglada M; San Martín R; Sobrevia L
    Circ Res; 2005 Jul; 97(1):16-24. PubMed ID: 15933265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
    Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.
    Muñoz G; San Martín R; Farías M; Cea L; Vecchiola A; Casanello P; Sobrevia L
    J Cell Physiol; 2006 Dec; 209(3):826-35. PubMed ID: 16924660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
    Hammond JR; Stolk M; Archer RG; McConnell K
    Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.
    Visser F; Baldwin SA; Isaac RE; Young JD; Cass CE
    J Biol Chem; 2005 Mar; 280(12):11025-34. PubMed ID: 15649894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.
    Sundaram M; Yao SY; Ng AM; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1998 Aug; 273(34):21519-25. PubMed ID: 9705281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
    Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.